[Clinical applications of the radioimmunoassay of carcinoembryonic antigen].
The clinical applications of the radioimmunoassay evaluation of the carcinoembryonic antigen (CEA) are examined here, with special reference to the follow-up of patients undertaking radiotherapy for uterus cancers, portio and bladder cancers, whether after surgery of not. In addition the Authors point out the levels of negativity for every test method, so that the possible crossed reaction with CEA-like substances can be taken into account.
D000951:Antigens, Neoplasm / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003429:Cross Reactions; D005260:Female; D006801:Humans; D011863:Radioimmunoassay; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000628:therapy; D014594:Uterine Neoplasms / Q000276:immunology* / Q000628:therapy
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen
Applicazioni cliniche del dosaggio radioimmunologico dell'antigene carcinoembrionale.